NEW YORK, Feb. 16, 2016 /PRNewswire/ -- Bronstein,
Gewirtz & Grossman, LLC, notifies investors of class action
against Cardiovascular Systems, Inc. ("Cardiovascular Systems" or
the "Company") (NASDAQ: CSII). The class action has been
filed on behalf of a class consisting of all persons or entities
who purchased Cardiovascular Systems, Inc. securities during the
period between September 12, 2011 and
January 21, 2016 inclusive (the
"Class Period").
This class action seeks to recover damages against Defendants
for alleged violations of the federal securities laws under the
Securities Exchange Act of 1934 (the "Exchange
Act").
Cardiovascular Systems, Inc. is a company devoted to developing
and commercializing innovative solutions for treating peripheral
and coronary vascular disease.
The Complaint alleges that throughout the Class Period,
Defendants issued materially false and misleading statements to
investors and/or failed to disclose that: (1) Cardiovascular
Systems distributed illegal kickbacks to healthcare providers; (2)
Cardiovascular Systems engaged in off-label promotion of its
medical devices; and (3) Cardiovascular Systems violated FDA laws
and regulations in connection with its medical devices. As a result
of this, Cardiovascular Systems' public statements were materially
false and misleading at relevant times. Following this information
entering the market, investors suffered damages.
A class action lawsuit has already been filed. If you wish to
review a copy of the Complaint and join the action, visit the
firm's website: http://www.bgandg.com/#!csii/pz0v2. To discuss this
action, or have any questions, please contact Peretz Bronstein, Esq. or his Investor Relations
Analyst, Yael Hurwitz of Bronstein,
Gewirtz & Grossman, LLC at 212-697-6484 or via email
info@bgandg.com. Those who inquire by e-mail are encouraged to
include their mailing address and telephone number. If you
suffered a loss in Cardiovascular Systems you have until
April 12, 2016 to request that
the Court appoint you as lead plaintiff. Your ability to
share in any recovery doesn't require that you serve as a lead
plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation
boutique. Our primary expertise is the aggressive pursuit of
litigation claims on behalf of our clients. In addition to
representing institutions and other investor plaintiffs in class
action security litigation, the firm's expertise includes general
corporate and commercial litigation, as well as securities
arbitration. Attorney advertising. Prior results do not
guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-notifies-investors-of-class-action-against-cardiovascular-systems-inc-csii-and-lead-plaintiff-deadline-april-12-2016-300220671.html
SOURCE Bronstein, Gewirtz & Grossman, LLC